Recent News

567 News Items found
CAR T cell therapy
In the Clinic
Cell therapies that use patients’ own immune cells to attack cancer — including CAR T cell therapy, an approach developed at MSK — are a promising and rapidly growing area of research.
Epigenetics
Q&A
An experimental drug for acute myelogenous leukemia might potentially help many more patients than previously thought by controlling epigenetic processes, according to a recent MSK study.
Neurons created from embryonic stem cells
In the Lab
A new tool called optogenetics is revealing clues about the function of a promising experimental therapy derived from stem cells.
Pictured: Viviane Tabar
In the Lab
Investigators have created the first-ever genetically engineered model of cancer made from human embryonic stem cells in culture.
MSK investigators Michael Berger and David Solit.
Finding
A study of one patient’s disease has clarified why tumors stop responding to a class of experimental drugs called PI3K inhibitors.
Pictured: William Lee, Chris Sander & Nils Weinhold
In the Lab
In a study of patient tumor samples, researchers have found common mutations in parts of the genome that control gene regulation.
Cancer biologist Andrea Ventura
In the Lab
MSK scientists have created a mouse model that replicates a subtype of non-small cell lung cancer caused by a chromosomal rearrangement.
A student asks a question at last year’s "Major Trends” seminar.
Event
Every year, MSK gives high school students and their teachers the opportunity to learn about cutting-edge biomedical research from our scientists.
Pictured: Pseudomonas aeruginosa
In the Lab
MSK researchers discover that the body senses and attacks harmful bacteria indirectly after the pathogens cause stress within the cells.
Pictured: Scott Lowe
In the Lab
In taking a new approach to finding treatments for hepatocellular carcinoma, MSK scientists have uncovered a potential drug target for this highly aggressive cancer.